Tamsulosin Hydrochloride Capsule
Product Images NDC 71205-217

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 71205-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-217-14 (Tamsulosin 30s Container)

Label for Tamsulosin Hydrochloride 0.4 mg capsules by Proficient Rx LP. The label states a quantity of 14 capsules, each containing 0.4 mg of tamsulosin hydrochloride USP. Capsules are described as hard gelatin with an olive green opaque cap and orange opaque body, imprinted with "TAM" on cap and "0.4 mg" on body in black ink. Manufactured by Alkem Laboratories Ltd, Mumbai, India.*

FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

A line graph showing plasma concentration (ng/mL) over time (hours) comparing fasted and fed states. The graph has time on the x-axis from 0 to 36 hours and plasma concentration on the y-axis from 0 to 25 ng/mL, with separate curves representing drug levels under fasted and fed conditions.*

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

A line graph showing mean change over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The x-axis represents treatment duration from baseline to 13 weeks and LOCF, while the y-axis shows mean change values. Different markers distinguish the treatments, illustrating their comparative effects over time.*

FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

A line graph depicting mean change over the duration of treatment in weeks for different groups treated with Tamsulosin Hydrochloride 0.8 mg, 0.4 mg, and placebo. The graph includes four lines representing these groups and shows the sample size for each time point.*

FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

A line graph depicting mean change in urine flow rate (mL/sec) over treatment duration in weeks. It compares three groups: 0.8 mg and 0.4 mg doses of the treatment, and placebo. Both treatment groups show a rapid increase in flow rate initially, maintaining higher levels than placebo throughout the study period.*

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

Line chart showing mean change in mL/sec over weeks of treatment for three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. Mean change trends are plotted against treatment duration in weeks, with sample sizes noted at various time points.*

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

Chemical structure of Tamsulosin Hydrochloride, depicted with aromatic rings, a methoxy group, an amide linkage, and hydrochloride salt representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.